Transgene expression of bcl-x(L) permits anti-immunoglobulin (Ig)- induced proliferation in xid B cells

Journal of Experimental Medicine

Volumn 187, Issue 7, 1998, Pages 1081-1091

  Solvason, Nanette ^a   Wu, Wei Wei ^a   Kabra, Nisha ^a   Lund Johansen, Fridjtof ^a   Roncarolo, Maria Grazia ^a   Behrens, Timothy W ^b   Grillot, Didier A M ^c   Nunez, Gabriel ^c   Lees, Emma ^a   Howard, Maureen ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; LYMPHOCYTE ANTIGEN RECEPTOR; MONOCLONAL ANTIBODY; PROTEIN BCL 2; PROTEIN TYROSINE KINASE; REGULATOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL CYCLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; IMMUNE DEFICIENCY; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENE;

ANIMALS; ANTIGENS, CD; APOPTOSIS; B-LYMPHOCYTES; BCL-X PROTEIN; BROMODEOXYURIDINE; CELL COUNT; CELL CYCLE; CELL SURVIVAL; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; IMMUNOGLOBULINS; MICE; MICE, INBRED CBA; MICE, TRANSGENIC; PHENOTYPE; PROTEIN KINASES; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2; SPLEEN;

EID: 2642617810     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.187.7.1081     Document Type: Article

References (41)

1. Billups, L.G., K. Lassoued, C. Nunez, J. Wang, H. Kubagawa, G.L. Gartland, P.D. Burrows, and M.D. Cooper. 1995. Human B-cell development. Ann. N.Y. Acad. Sci. 764: 1-8.
2. Satterthwaite, A., and O.N. Witte. 1996. Genetic analysis of tyrosine kinase function in B cell development. Annu. Rev. Immunol. 14:131-154.
3. Yel, L., Y. Minegishi, E. Coustan-Smith, R.H. Buckley, H. Trubel, L. Pachman, G.T. Kitchingman, D. Campana, J. Rohrer, and M.E. Conley. 1996. Mutations in the mu heavy-chain gene in patients with agammaglobulinemia. N. Engl. J. Med. 335:1486-1493.
4. Kitamura, D., J. Roes, R. Kurn, and K. Rajewsky. 1991. A B cell deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature. 350: 423-426.
5. Thomas, J.D., P. Sideras, C.I.E. Smith, I. Vorechovsk, V. Chapman, and W.E. Paul. 1993. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Science. 261:355-358.
6. Rawlings, D.J., D. Saffron, D. Tsukada, D. Largaespada, J.C. Grimaldi, L. Cohen, R.N. Morh, F.J. Bazan, M. Howard, N.G. Copeland, N.A. Jenkings, and O.N. Witte. 1993. Mutations in unique region of Btk in immunodeficient XID mice. Science. 261:358-361.
7. Khan, W.N., F.W. Alt, R.M. Gerstein, B.A. Malynn, I. Larsson, G. Rathbun, L. Davidson, S. Muller, A.B. Kantor, L.A. Herzenberg, R.S. Rosen, and P. Sideras. 1995. Defective B cell development and function in Btk-deficient mice. Immunity. 3:283-299.
8. Lerner, J.D., M.W. Appleby, R.N. Morh, S. Chien, D.J. Rawlings, C.R. Maliszewski, O.N. Witte, and R.M. Perlmutter. 1995. Impaired expansion of mouse B cell progenitors lacking Btk. Immunity. 3:301-312.
9. Tsukada, S., D.C. Saffran, D.J. Rawlings, O. Parolini, R.C. Allen, I. Klisak, R.S. Sparkes, H. Kubagawa, T. Mohandas, S. Quan, J.W. Belmont, M.D. Cooper, M.E. Conley, and O.N. Witte. 1993. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell. 72:279-284.
10. Vetrie, D., I. Vorechovsky, P. Sideras, P. Holand, A. Davies, A. Flinter, A.L. Hammarstrom, C. Kinnon, R. Levinsky, M. Bobrow, et al. 1993. The gene involved in X-linked agammaglobulinemia is a member of the src family of protein-tyrosine kinases. Nature. 361:226-229.
11. Conley, M.E., O. Parolini, J. Rohrer, and D. Campana. 1994. X-linked agammaglobulinemia: new approaches to old questions based on the identification of the detective gene. Immunol. Rev. 138:5-21.
12. Scher, I. 1982. The CBA/n mouse strain; an experimental model illustrating the influence of the X-chromosome on immunity. Adv. Immunol. 33:1-71.
13. Oka, Y., A.G. Rolink, J. Andersson, M. Kamanaka, J. Uchida, T. Yasui, H. Kishimoto, H. Kikutani, and F. Melchers. 1996. Profound reduction of mature B cell numbers, reactivities and serum Ig levels in mice which simultaneously carry the XID and CD40 deficiency genes. Int. Immunol. 8:1675-1685.
14. Hardy, R.R., K. Hayakawa, D.R. Parks, and L.A. Herzenberg. 1983. Demonstration of B cell maturation in X-linked immunodeficient mice by simultaneous 3-color immunofluorescence. Nature. 306:270-272.
15. Mosier, D. 1985. Are xid B lymphocytes representative of any normal B cell population? J. Mol. Cell. Immunol. 2:70-78.
16. Hayakawa, K., R.R. Hardy, and L.A. Herzenberg. 1986. Peritoneal Ly1 B cells: genetic control and autoantibody production. Eur. J. Immunol. 16:450-465.
17. Melchers, F., D. Haasner, U. Grawunder, C. Kalberer, H. Karasuyama, T. Winkler, and A.G. Rolink. 1994. Roles of IgH and L chains and of surrogate H and L chains in the development of cells of the B lymphocyte lineage. Annu. Rev. Immunol. 12:209-225.
18. Wortis, H.H. 1992. Surface markers, heavy chain sequences and B cell lineages. Int. Rev. Immunol. 8:235-246.
19. Sherr, C.J. 1996. Cancer cell cycle. Science. 274:1672-1677.
20. Lees, E. 1995. Cyclin dependent kinase regulation. Curr. Opin. Cell Biol. 7:773-780.
21. Weinberg, R.A. 1995. The retinoblastoma protein and cell cycle control. Cell. 81:323-330.
22. Evan, G.I., L. Brown, M. Whyte, and E. Harrington. 1995. Apoptosis and the cell cycle. Curr. Opin. Cell Biol. 7:825-834.
23. Pandey, S., and E. Wang. 1995. Cells en route to apoptosis are characterized by the upregulation of c-fos, c-myc, c-jun, cdc2, and RB phosphorylation, resembling events of early cell-cycle traverse. J. Cell. Biochem. 58:135-150.
24. Fanidi, A., E. Harrington, and G.I. Evan. 1992. Cooperative interaction between c-myc and Bcl-2 proto-oncogenes. Nature. 359:554-556.
25. Fukada, T., M. Hibi, Y. Tamanaka, M. Takahashi-Texuka, Y. Fujitani, T. Tamaguchi, K. Nakajima, and T. Hirano. 1996. Two signals are necessary for cell proliferation induced by a cytokine receptor gp!30: involvement of STAT 3 in anti-apoptosis. Immunity. 5:449-460.
26. L transgene. Immunity. 4:291-299.
27. Grillot, D.A.M., R. Merino, J.C. Pena, W.C. Fanslow, F.D. Finkelman, C.B. Thompson, and G. Nunez. 1996. bcl-x exhibits regulated expression during B cell development and activation and modulates lymphocyte survival in transgenic mice. J. Exp. Med. 183:381-391.
28. Choi, M.S.K., M. Holman, C.J. Atkins, and G.G.B. Klaus. 1996. Expression of bcl-x during mouse B cell differentiation and following activation by various stimuli. Eur. J. Immunol. 26:676-682.
29. Anderson, J.S., M. Teutsch, Z. Dong, and H.H. Wortis. 1996. An essential role for Bruton's tyrosine kinase in the regulation of B-cell apoptosis. Proc. Natl. Acad. Sci. USA. 93: 10966-10971.
30. Motoyama, N., F. Want, K.A. Roth, H. Sawa, K. Nakayama, K. Nakayama, I. Negishi, S. Senju, Q. Zhang, S. Fujii, and D.Y. Loh. 1995. Massive cell death of immature hematopoietic cells and neurons in bcl-x-deficient mice. Science. 267:1506-1510.
31. Heath, A.W., W.W. Wu, and M.C. Howard. 1994. Monoclonal antibodies to murine CD40 define two distinct functional epitopes. Eur. J. Immunol. 24:1828-1834.
32. Solvason, N., W.W. Wu, N. Kabra, X. Wu, E. Lees, and M.C. Howard. 1996. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes. J. Exp. Med. 184:407-417.
33. Draetta, G., and D. Beach. 1988. Activation of cdc2 protein kinase during mitosis in human cells: cell cycle-dependent phosphorylation and subunit rearrangement. Cell. 54:17-26.
34. Carayon, P., and A. Bord. 1992. Identification of DNA-replicating lymphocyte subsets using a new method to label the bromo-deoxyuridine incorporated into the DNA. J. Immunol. Methods. 147:225-230.
35. Ferlin, W.G., E. Severinson, L. Strom, A.W. Heath, R.L. Coffman, D.A. Ferrick, and M.C. Howard. 1996. CD40 signaling induces interleukin-4-independent IgE switching in vivo. Eur. J. Immunol. 26:2911-2915.
36. Sieckmann, D.G., I. Scher, R. Asorsky, D.E. Mosier, and W.E. Paul. 1978. Activation of mouse lymphocytes by anti-IgM. II. A thymus-independent response by a mature subset of B lymphocytes. J. Exp. Mcd. 148: 1628-1643.
37. Lund-Johansen, F., T. Frey, J.A. Ledbetter, and P.A. Thompson. 1996. Apoptosis in hematopoietic cells is associated with an extensive decrease in cellular phosphotyrosine content that can be inhibited by the tyrosine phosphatase antagonist pervanadate. Cytometry. 25:182-190.
38. DeFranco, A.L., J.T. Kung, and W.E. Paul. 1982. Regulation of growth and proliferation in B cell subpopulations. Immunol. Rev. 64:161-182.
39. Woodland, R.T., M.R. Schmidt, S.J. Korsmeyer, and K.A. Gravel. 1996. Regulation of D cell survival in xid mice by the proto-oncogene bcl-2. J. Immunol. 156:2143-2154.
40. Lindsberg, M.-L., M. Brunswick, H. Yamada, A. Lees, J. Inman, C.H. June, and J.J. Mond. 1991. Biochemical analysis of the immune B cells defect in xid mice. J. Immunol. 147: 3774-3779.
41. Solvason, N., A. Lehuen, and J.F. Kearney. 1991. An embryonic source of Ly1 but not conventional B cells. Inter. Immunol. 3:543-550.